Seasonal Influenza in Canada-Free-Samples-Myassignmenthelp.com

Question: Discuss the most pressing Infectious Disease in the Community. Answer: Influenza commonly known as flu is one of the most pressing infectious disease present in the community. The influenza disease caused by different influenza virus is highly contagious as it easily get transmitted from one person to another by air droplets when an infected person cough. It mainly affected the nose, throat and lungs and causes illness in about 5-20% US population each year. Influenza infection is associated with symptoms like fever, chills, muscle pain, fatigue and runny nose. In certain cases severe complication are also seen and this is the reason for about 2,00,000 hospitalization in US each year. There is also reported case of about 49,000 deaths every year due to influenza related complications. To control this pressing infection, the public health agency focuses on influenza vaccination coverage every year. According to the Centers for Disease Control and Prevention (CDS), children should get vaccinated before early fall because the activity of the flu increases between the month of December and February (Influenza (Flu) 2017). Influenza vaccination is also a targeted program in many countries like Canada and United States. In case of Canada, the main purpose of influenza vaccination is to minimize serious complications and rate of hospitalization and death. There are certain age group of people who are at high risk of influenza infection such as older people above 65 years, infants between 6 months to 5 years and people suffering from other medical comorbidities (Thommes et al. 2017). Hence, the National Advisory Committee on Immunization emphasize on vaccination in people with high risk of influenza infection. References Influenza (Flu). 2017.Nfid.org. Retrieved 18 November 2017, from https://www.nfid.org/influenza Thommes, E.W., Kruse, M., Kohli, M., Sharma, R. and Noorduyn, S.G., 2017. Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines.Human vaccines immunotherapeutics,13(4), pp.867-876